Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion

PURPOSE: To assess treatment interval extension after switching from ranibizumab to aflibercept intravitreal injections in macular edema (ME) due to central retinal vein occlusion (CRVO) with an insufficient response or frequent recurrences to initial treatment. METHODS: CRVO eyes treated with ranib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Ophthalmol
Main Authors: Nghiem-Buffet, Sylvia, Glacet-Bernard, Agnès, Addou-Regnard, Manar, Souied, Eric H., Cohen, Salomon Y., Giocanti-Auregan, Audrey
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079418/
https://ncbi.nlm.nih.gov/pubmed/30116635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8656495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados